Fgf13 Knockout Reduces Cardiac Fibrosis
Author Information
Author(s): Wang Cong, Wang Xiangchong, Zhang Yiyi, Mi Yuan, Han Yanxue, Zhi Yaxin, Zhao Ran, Cui Nanqi, Ma Qianli, Zhang Huaxing, Xue Dazhong, Qiao Ruoyang, Han Jiabing, Yu Yulou, Li Jiaxuan, Shaiea Mohammed, Liu Demin, Gu Guoqiang, Wang Chuan
Primary Institution: Hebei Medical University
Hypothesis
Fgf13 knockdown can promote fibroblast function by regulating the stability of microtubules and ROCK pathway, and thereby participate in cardiac fibrosis.
Conclusion
Fgf13 knockout protects the heart from fibrosis in response to haemodynamic stress by modulating microtubule stabilization and ROCK signaling pathway.
Supporting Evidence
- Fgf13 knockout mice showed reduced cardiac fibrosis following pressure overload.
- FGF13 expression was significantly increased in TGFβ-treated fibroblasts.
- Fgf13 knockdown decreased fibroblast proliferation and migration.
- Fgf13 knockout hearts maintained cardiac function under pressure overload.
- Colchicine inhibited fibroblast activation and function during the fibrotic response.
Takeaway
This study found that removing a protein called Fgf13 helps prevent heart scarring in mice, which can happen when the heart is under stress.
Methodology
The study used Fgf13 conditional knockout mice and various in vitro assays to assess fibroblast activation and function.
Limitations
The study acknowledges potential injuries during TAC surgery that could affect results.
Participant Demographics
Adult male C57BL/6J mice aged 8 to 16 weeks were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website